Jazz Pharmaceuticals plc Cash Flow Quality Index
Jazz Pharmaceuticals plc cash flow quality index. Jazz Pharmaceuticals plc (J7Z) has a Cash Flow Quality Index of 1.39x as of March 2026. Operating cash flow of €408.20 Million exceeds net income of €293.10 Million, indicating high earnings quality where cash backs reported profits. See J7Z financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jazz Pharmaceuticals plc (2013–2024)
Cash flow quality index of Jazz Pharmaceuticals plc from 2013 to 2024. Historical Cash Flow Quality Index for Jazz Pharmaceuticals plc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore J7Z cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Jazz Pharmaceuticals plc Cash Flow Quality Index by Year (2013–2024)
Jazz Pharmaceuticals plc cash flow quality index by year from 2013 to 2024. Year-by-year earnings quality comparison for Jazz Pharmaceuticals plc. For the full cash flow conversion analysis, see J7Z cash generation efficiency.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.49x | €1.40 Billion | €560.12 Million | ▼ -5.3% |
| 2023 | 2.63x | €1.09 Billion | €414.83 Million | ▼ -30.2% |
| 2020 | 3.77x | €899.65 Million | €238.62 Million | ▲ +154.2% |
| 2019 | 1.48x | €776.40 Million | €523.37 Million | ▼ -17.0% |
| 2018 | 1.79x | €798.90 Million | €447.10 Million | ▲ +25.8% |
| 2017 | 1.42x | €693.09 Million | €487.85 Million | ▼ -4.8% |
| 2016 | 1.49x | €592.39 Million | €396.83 Million | ▼ -7.5% |
| 2015 | 1.61x | €531.94 Million | €329.54 Million | ▼ -76.9% |
| 2014 | 6.98x | €407.61 Million | €58.39 Million | ▲ +423.6% |
| 2013 | 1.33x | €288.43 Million | €216.31 Million | — |